PURE Stock Overview
Develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PURE Bioscience, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.071 |
| 52 Week High | US$0.17 |
| 52 Week Low | US$0.063 |
| Beta | 0.11 |
| 11 Month Change | -7.91% |
| 3 Month Change | -28.28% |
| 1 Year Change | -21.11% |
| 33 Year Change | -84.40% |
| 5 Year Change | -79.61% |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| PURE | US Household Products | US Market | |
|---|---|---|---|
| 7D | -5.5% | 0.3% | -0.5% |
| 1Y | -21.1% | 11.9% | 24.2% |
Return vs Industry: PURE underperformed the US Household Products industry which returned 11.9% over the past year.
Return vs Market: PURE underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| PURE volatility | |
|---|---|
| PURE Average Weekly Movement | 26.0% |
| Household Products Industry Average Movement | 3.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: PURE's share price has been volatile over the past 3 months.
Volatility Over Time: PURE's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 12 | Robert Bartlett | www.purebio.com |
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces.
PURE Bioscience, Inc. Fundamentals Summary
| PURE fundamental statistics | |
|---|---|
| Market cap | US$7.94m |
| Earnings (TTM) | -US$3.63m |
| Revenue (TTM) | US$2.09m |
3.8x
P/S Ratio-2.2x
P/E RatioIs PURE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PURE income statement (TTM) | |
|---|---|
| Revenue | US$2.09m |
| Cost of Revenue | US$893.00k |
| Gross Profit | US$1.20m |
| Other Expenses | US$4.82m |
| Earnings | -US$3.63m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 57.29% |
| Net Profit Margin | -173.41% |
| Debt/Equity Ratio | -111.8% |
How did PURE perform over the long term?
See historical performance and comparison